ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

NCI To Send Eight To AIDS Conference, Few Will Attend Cancer Meetings

February 28, 1992

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014